Report the ad
Unleashing the Power of Sotorasib 120 mg in India for Cancer Treatment - Delhi
Wednesday, 27 March, 2024
Item details
City:
Delhi
Offer type:
Offer
Item description
Sotorasib tablet also known by its brand name Lumakras, is a precision medicine specifically designed to target a common genetic mutation found in non-small cell lung cancer (NSCLC) – the KRAS G12C mutation. This mutation, previously considered "undruggable," now has a targeted therapy that directly inhibits the mutated protein. It hinders tumor growth and progression. Sotorasib 120 mg in India offers a newfound hope and optimism for the treatment of NSCLC. Unlike traditional chemotherapy, it is well-tolerated, with manageable side effects that allow patients to maintain their health while undergoing treatment. Impomed Healthcare strives to empower patients with this drug to combat cancer and reclaim their health and well-being.
Related ads
Cobimetinib 20 mg is a groundbreaking cancer treatment, specifically targeting BRAF V600E…
Natural Herbal Cancer Cure treatment in India Matrix Biopharma Industries is a renowned name in…
Venetoclax, a novel oral medication, represents a paradigm shift in cancer therapy, particularly in…
Cobimetinib is classified as an MEK inhibitor, which means it works by blocking a protein called…
Selpercatinib 40 & 80 mg in India is a targeted therapy for RET fusion-positive non-small cell lung…
Venetoclax 100 mg is now available in India for the treatment of blood cancers like chronic…
Tucatinib 150 mg: Innovative Treatment for HER2-Positive Breast Cancer Patients (Delhi)
Tucatinib 150 mg is a groundbreaking treatment for HER2-positive breast cancer available in India…
Discover cutting-edge cancer treatment at Impomed Healthcare with our leading approach to…
Looking for rare and targeted life-saving medicines then MedsDots, a true Indian pharmacy, is an…
Enfortumab vedotin 20/30 mg in India is transforming the treatment landscape for advanced…
